{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:02:19Z","timestamp":1791846139396,"version":"4.3.4"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01383","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T04:19:05Z","timestamp":1529295545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Nicoletta","family":"Del Papa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","article-title":"Systemic sclerosis: an update in 2016","volume":"15","author":"Desbois","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B3","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subset and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts","volume":"14","author":"Rabquer","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","article-title":"Angiogenesis","volume":"57","author":"Folkman","year":"2006","journal-title":"Annu Rev Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.arr.2007.01.001","article-title":"The role of vascular stem cells in atherogenesis and post-angioplasty restenosis","volume":"6","author":"Qian","year":"2007","journal-title":"Ageing Res Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","article-title":"Cellular and molecular aspects of vascular dysfunction in systemic sclerosis","volume":"6","author":"Trojanowska","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.5966\/sctm.2015-0227","article-title":"Concise review: endothelial progenitor cells in regenerative medicine: applications and challenges","volume":"5","author":"Chong","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"B14","first-page":"411","article-title":"Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine","volume":"7","author":"Sukmawati","year":"2015","journal-title":"Am J Transl Res"},{"key":"B15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V95.3.952.003k27_952_958","article-title":"Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors","volume":"95","author":"Peichev","year":"2000","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.exphem.2007.04.002","article-title":"Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors","volume":"3","author":"Case","year":"2007","journal-title":"Exp Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1182\/blood-2008-08-173773","article-title":"Inhibition of endothelial progenitor cell differentiation by VEGI","volume":"113","author":"Tian","year":"2009","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-3-18","article-title":"Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities","volume":"3","author":"Medina","year":"2010","journal-title":"BMC Med Genomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/sctm.16-0360","article-title":"Endothelial progenitors: a consensus statement on nomenclature","volume":"6","author":"Medina","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2119\/molmed.2011.00129","article-title":"Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8","volume":"17","author":"Medina","year":"2011","journal-title":"Mol Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1161\/ATVBAHA.107.155960","article-title":"Assessing identity, phenotype, and fate of endothelial progenitor cells","volume":"28","author":"Hirschi","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00395-012-0310-4","article-title":"Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis","volume":"108","author":"Kanzler","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/sj.cr.7310075","article-title":"Adult endothelial progenitor cells from human peripheral blood maintain monocyte\/macrophage function throughout in vitro culture","volume":"16","author":"Zhang","year":"2006","journal-title":"Cell Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","article-title":"Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals","volume":"109","author":"Yoder","year":"2007","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.RES.0000105569.77539.21","article-title":"Diverse origin and function of cells with endothelial phenotype obtained from adult human blood","volume":"93","author":"Gulati","year":"2003","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1182\/blood-2006-12-062471","article-title":"In vivo vasculogenic potential of human blood-derived endothelial progenitor cells","volume":"109","author":"Melero-Martin","year":"2007","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00018-017-2662-2","article-title":"Vascular stem\/progenitor cells: functions and signaling pathways","volume":"75","author":"Lu","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/CIRCULATIONAHA.104.503433","article-title":"Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases","volume":"112","author":"Yoon","year":"2005","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/7434","article-title":"Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization","volume":"5","author":"Takahashi","year":"1999","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/01.moh.0000219664.26528.da","article-title":"Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue","volume":"13","author":"Kopp","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.HYP.0000154789.28695.ea","article-title":"Mobilizing endothelial progenitor cell","volume":"45","author":"Aicher","year":"2005","journal-title":"Hypertension"},{"key":"B34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2217\/bmm.11.92","article-title":"Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent","volume":"5","author":"Grisar","year":"2011","journal-title":"Biomark Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/biof.1016","article-title":"Endothelial progenitor cells in diabetes mellitus","volume":"38","author":"Menegazzo","year":"2012","journal-title":"Biofactors"},{"key":"B36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/hc2301.092122","article-title":"Mobilization of endothelial progenitor cells in patients with acute myocardial infarction","volume":"103","author":"Shintani","year":"2001","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/01.RES.88.2.167","article-title":"Vascular trauma induces rapid but transient mobilization of VEGFR2(+)\/AC133(+) endothelial precursor cells","volume":"88","author":"Gill","year":"2001","journal-title":"Circ Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1002\/art.24921","article-title":"Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases","volume":"60","author":"Distler","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/art.20116","article-title":"Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis","volume":"50","author":"Del Papa","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B42","first-page":"60","article-title":"Levels of circulating endothelial progenitor cells in systemic sclerosis","volume":"1","author":"Allanore","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/ard.2007.082131","article-title":"Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity","volume":"67","author":"Avouac","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B44","first-page":"421","article-title":"Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations","volume":"26","author":"Nevskaya","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1161\/CIRCULATIONAHA.108.787200","article-title":"Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells","volume":"118","author":"Zhu","year":"2008","journal-title":"Circulation"},{"key":"B46","first-page":"S19","article-title":"Low circulating level of CD133+KDR+cells in patients with systemic sclerosis","volume":"28","author":"Mok","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mvr.2015.01.004","article-title":"Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis","volume":"98","author":"Andrigueti","year":"2015","journal-title":"Microvasc Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1634\/stemcells.2006-0026","article-title":"Endothelial differentiation potential of human monocyte-derived multipotential cells","volume":"24","author":"Kuwana","year":"2006","journal-title":"Stem Cells"},{"key":"B49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.14670\/HH-28.175","article-title":"Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis","volume":"28","author":"Yamaguchi","year":"2013","journal-title":"Histol Histopathol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3324\/haematol.12526","article-title":"CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis","volume":"93","author":"Campioni","year":"2008","journal-title":"Haematologica"},{"key":"B51","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1186\/ar3180","article-title":"Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.107.694778","article-title":"Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies","volume":"116","author":"Hur","year":"2007","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/annrheumdis-2013-204250","article-title":"Angiogenic T cells are decreased in rheumatoid arthritis patients","volume":"74","author":"Rodr\u00edguez-Carrio","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2842143","DOI":"10.1155\/2016\/2842143","article-title":"Circulating angiogenic T cells and their subpopulations in patients with systemic lupus erythematosus","volume":"2016","author":"Miao","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13075-016-1044-8","article-title":"Endothelial progenitor cells are differentially impaired in ANCA-associated vasculitis compared to healthy controls","volume":"18","author":"Wilde","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0183102","DOI":"10.1371\/journal.pone.0183102","article-title":"Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis","volume":"12","author":"Manetti","year":"2017","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/annrheumdis-2011-200713","article-title":"Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols","volume":"71","author":"Kuwana","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/ard.2008.091918","article-title":"EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells","volume":"68","author":"Distler","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/art.22035","article-title":"Bone marrow endothelial progenitors are defective in systemic sclerosis","volume":"54","author":"Del Papa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptor leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ Res"},{"key":"B61","first-page":"1529","article-title":"Elevated vascular endothelial growth factor in systemic sclerosis","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1186\/ar4217","article-title":"Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis","volume":"15","author":"Avouac","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13075-015-0848-2","article-title":"Inhibition of angiogenesis by platelets in systemic sclerosis patients","volume":"17","author":"Hirigoyen","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13075-016-0937-x","article-title":"The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?","volume":"18","author":"Manetti","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13075-017-1271-7","article-title":"Increased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis","volume":"19","author":"Benyamine","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2014.03.052","article-title":"Exogenous fractalkine enhances proliferation of endothelial cells, promotes migration of endothelial progenitor cells and improves neurological deficits in a rat model of ischemic stroke","volume":"569","author":"Qin","year":"2014","journal-title":"Neurosci Lett"},{"key":"B68","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/cvr\/cvv111","article-title":"Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression","volume":"106","author":"Herlea-Pana","year":"2015","journal-title":"Cardiovasc Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3899\/jrheum.091346","article-title":"Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis","volume":"37","author":"Del Papa","year":"2010","journal-title":"J Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/art.38953","article-title":"Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis","volume":"67","author":"Shirai","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12979-016-0080-1","article-title":"The inflammatory protein pentraxin 3 in cardiovascular disease","volume":"13","author":"Fornai","year":"2016","journal-title":"Immun Ageing"},{"key":"B72","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3899\/jrheum.080343","article-title":"Increased serum pentraxin 3 in patients with systemic sclerosis","volume":"36","author":"Iwata","year":"2009","journal-title":"J Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1002\/art.30536","article-title":"Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells","volume":"63","author":"Avouac","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B74","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/01.RES.0000120861.27064.09","article-title":"Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation","volume":"94","author":"Bruhl","year":"2004","journal-title":"Circ Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1084\/jem.20042097","article-title":"Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells","volume":"201","author":"R\u00f6ssig","year":"2005","journal-title":"J Exp Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1186\/ar4349","article-title":"Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis","volume":"15","author":"Manetti","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","article-title":"Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis","volume":"75","author":"Romano","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood-2011-10-322446","article-title":"EGFL7: a unique angiogenic signaling factor in vascular development and disease","volume":"119","author":"Nichol","year":"2012","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/art.40229","article-title":"Role of stromelysin 2 (matrix metalloproteinase 10) as a novel mediator of vascular remodeling underlying pulmonary hypertension associated with systemic sclerosis","volume":"69","author":"Avouac","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1128\/IAI.00799-07","article-title":"Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa","volume":"75","author":"Kassim","year":"2007","journal-title":"Infect Immun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1023\/A:1023889805133","article-title":"The role of the matrix metalloproteinases during in vitro vessel formation","volume":"5","author":"Burbridge","year":"2002","journal-title":"Angiogenesis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1096\/fj.14-259689","article-title":"Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia","volume":"29","author":"Gomez-Rodriguez","year":"2015","journal-title":"FASEB J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"835948","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E2157","DOI":"10.3390\/ijms18102157","article-title":"TGF-\u03b2-induced endothelial-mesenchymal transition in fibrotic diseases","volume":"18","author":"Pardali","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.matbio.2016.01.012","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of systemic sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?","volume":"51","author":"Jimenez","year":"2016","journal-title":"Matrix Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12891-016-1197-2","article-title":"Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) \u2013 dynamics of cellular regeneration and mesenchymal transdifferentiation","volume":"17","author":"Patschan","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"B89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addr.2017.09.001","article-title":"Stem cell-based peripheral vascular regeneration","volume":"120","author":"Fujita","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"B90","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12026-013-8409-8","article-title":"Statins and autoimmunity","volume":"56","author":"Khattri","year":"2013","journal-title":"Immunol Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/1158822-S0-000000000-00000","article-title":"Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering","volume":"10","author":"Pedersen","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"B92","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1172\/JCI200113131","article-title":"HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells","volume":"108","author":"Llevadot","year":"2001","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1172\/JCI200113152","article-title":"HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway","volume":"108","author":"Dimmeler","year":"2001","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1586\/14779072.6.8.1071","article-title":"Pharmacological approaches to improve endothelial repair mechanisms","volume":"6","author":"Besler","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.semarthrit.2015.10.013","article-title":"A review of the effects of statins in systemic sclerosis","volume":"45","author":"Ladak","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/art.21899","article-title":"Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis","volume":"54","author":"Kuwana","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B97","first-page":"1323","article-title":"Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis","volume":"35","author":"Del Papa","year":"2008","journal-title":"J Rheumatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","article-title":"Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization","volume":"102","author":"Heeschen","year":"2003","journal-title":"Blood"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.jacc.2006.08.031","article-title":"Protective effects of erythropoietin in cardiac ischemia: from bench to bedside","volume":"48","author":"Lipsic","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1365-2230.2010.03847.x","article-title":"Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers","volume":"35","author":"Ferri","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/rheumatology\/keq259","article-title":"Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis","volume":"49","author":"Furuya","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/art.38326","article-title":"Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis","volume":"66","author":"Kuwana","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/rheumatology\/ken407","article-title":"Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis","volume":"48","author":"Nevskaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5301\/jsrd.5000222","article-title":"Adipose-derived cell transplantation in systemic sclerosis: state of the art and future perspectives","volume":"2","author":"Del Papa","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"B105","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3727\/096368914X674062","article-title":"Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis","volume":"24","author":"Del Papa","year":"2015","journal-title":"Cell Transplant"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3727\/096368914X685636","article-title":"Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis","volume":"24","author":"Del Papa","year":"2015","journal-title":"Cell Transplant"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","article-title":"Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial","volume":"74","author":"Granel","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","article-title":"Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L","volume":"22","author":"Christopeit","year":"2008","journal-title":"Leukemia"},{"key":"B109","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann Intern Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/art.30431","article-title":"Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases","volume":"63","author":"Keyszer","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T15:04:23Z","timestamp":1571497463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":110,"alternative-id":["10.3389\/fimmu.2018.01383"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01383","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"article-number":"1383"}}